(2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-((6-((4-(1-methyl-1,2,5,6-tetrahydropyridin-3-yl)-1,2,5-thiadiazol-3-yl)oxy)hexan-3-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid-13CD3
Xanomeline Metabolite C-13C-d3 is a fully characterized chemical compound used as a reference standard of API Xanomeline. The standard offered is compliant with regulatory guidelines. Xanomeline Metabolite C-13C-d3 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS -